Monitoring residual kidney function in haemodialysis patients using timed urine collections: validation of the use of estimated blood results to calculate GFR. (31st August 2022)

• Record Type: Journal Article
• Authors: Lindley, Elizabeth; Keane, David; Belcher, John; Fernandes Da Silva Jeffcoat, Nancy; Davies, Simon
• Is Part Of: Physiological measurement. Volume 43:Number 8(2022)
• Publication Date: 2022-08-31
• Subjects: residual kidney function -- hemodialysis -- kinetic modelling; Physiology -- Measurement -- Periodicals; Patient monitoring -- Periodicals; 612
• DOI: 10.1088/1361-6579/ac80e8
• Languages: English
• ISSNs: 0967-3334

Abstract

Abstract: Objective . With growing recognition of the benefits of preserving residual kidney function (RKF) and use of incremental treatment regimes, the incentive to measure residual clearance in haemodialysis patients is increasing. Interdialytic urine collections used to monitor RKF in research studies are considered impractical in routine care, partly due to the requirement for blood samples before and after the collection. Plasma solute levels can be estimated if patients are in 'steady state', where urea and creatinine concentrations increase at a constant rate between dialysis sessions and are reduced by a constant ratio at each session. Validation of the steady state assumption would allow development of simplified protocols for urine collections in HD patients. Approach . Equations were derived for estimating plasma urea and creatinine at the start or end of the interdialytic interval for patients in steady state. Data collected during the BISTRO study was used to assess the agreement between measured and estimated plasma levels and the effect of using estimated levels on the calculated glomerular filtration rate (GFR). Main results . The mean difference between GFR calculated with estimated plasma levels for the HD session after the collection and a full set of measured levels was 2.0% (95% limits of agreement −10.7% to +14.7%, N = 316). Where plasma levels for the session before the collection were estimated, the mean difference was 1.2% (limits of agreement −10.3% to +7.9%, N = 275). Significance . Using estimated levels for one session led to a clinically significant difference in the calculated GFR for less than 3% of the collections studied. This indicates that the steady state assumption can be used to estimate solute levels when determining GFR from timed urine collections. A pragmatic approach to monitoring RKF in HD would be for patients to collect for approximately 24 h before routine bloods are taken.